Sponsor pipeline

Lexicon Pharmaceuticals clinical trial pipeline

1 active trials 0 recruiting 1 Phase 3 3 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-27

Primary completion pushed: 2026-07 → 2027-01
Completion pushed: 2026-08 → 2027-02

NCT06481891 A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive… · Phase 3

2026-07-30

Enrollment closed, study ongoing

NCT06481891 A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive… · Phase 3

Phase 3

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT06481891	A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive…	Obstructive Cardiomyopathy, Hypertrophic	Active, Not Recruiting	2026-08-26

Get alerts when Lexicon Pharmaceuticals's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.